You have free access to this content

Hepatology

Cover image for Vol. 46 Issue 6

December 2007

Volume 46, Issue 6

Pages 1671–2052

  1. Editorial

    1. Top of page
    2. Editorial
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Special Article
    11. Reviews
    12. Hepatology Elsewhere
    13. Correspondence
    14. Corrections
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
    4. You have free access to this content
      MARS and the failing liver—Any help from the outer space? (pages 1682–1684)

      Peter Ferenci and Ludwig Kramer

      Version of Record online: 28 NOV 2007 | DOI: 10.1002/hep.22031

    5. You have free access to this content
  2. Viral Hepatitis

    1. Top of page
    2. Editorial
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Special Article
    11. Reviews
    12. Hepatology Elsewhere
    13. Correspondence
    14. Corrections
    1. You have free access to this content
    2. You have free access to this content
      Hepatitis B virus DNA levels at week 4 of lamivudine treatment predict the 5-year ideal response (pages 1695–1703)

      Man-Fung Yuen, Daniel Yee-Tak Fong, Danny Ka-Ho Wong, John Chi-Hang Yuen, James Fung and Ching-Lung Lai

      Version of Record online: 20 NOV 2007 | DOI: 10.1002/hep.21939

    3. You have free access to this content
      Distinct hepatitis C virus core and F protein quasispecies in tumoral and nontumoral hepatocytes isolated via microdissection (pages 1704–1712)

      Rodolphe Sobesky, Cyrille Feray, François Rimlinger, Nicolas Derian, Alexandre Dos Santos, Anne-Marie Roque-Afonso, Didier Samuel, Christian Bréchot and Valérie Thiers

      Version of Record online: 12 OCT 2007 | DOI: 10.1002/hep.21898

    4. You have free access to this content
    5. You have free access to this content
      Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81 (pages 1722–1731)

      Mirjam B. Zeisel, George Koutsoudakis, Eva K. Schnober, Anita Haberstroh, Hubert E. Blum, François-Loïc Cosset, Takaji Wakita, Daniel Jaeck, Michel Doffoel, Cathy Royer, Eric Soulier, Evelyne Schvoerer, Catherine Schuster, Françoise Stoll-Keller, Ralf Bartenschlager, Thomas Pietschmann, Heidi Barth and Thomas F. Baumert

      Version of Record online: 14 NOV 2007 | DOI: 10.1002/hep.21994

    6. You have free access to this content
      Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: The role of rapid and early virologic response (pages 1732–1740)

      Sanaa M. Kamal, Samer S. El Kamary, Michelle D. Shardell, Mohamed Hashem, Imad N. Ahmed, Mohamed Muhammadi, Khalifa Sayed, Ashraf Moustafa, Sarah Abdel Hakem, Amany Ibrahiem, Mohamed Moniem, Hoda Mansour and Mohamed Abdelaziz

      Version of Record online: 17 OCT 2007 | DOI: 10.1002/hep.21917

    7. You have free access to this content
      Predictors of treatment in patients with chronic hepatitis C infection—Role of patient versus nonpatient factors (pages 1741–1749)

      Fasiha Kanwal, Tuyen Hoang, Brennan M.R. Spiegel, Seth Eisen, Jason A. Dominitz, Allen Gifford, Mathew Goetz and Steven M. Asch

      Version of Record online: 28 NOV 2007 | DOI: 10.1002/hep.21927

    8. You have free access to this content
      Liver disease in adolescents: A cohort study of high-risk individuals (pages 1750–1758)

      David Van der Poorten, Dianna T. Kenny, Tony Butler and Jacob George

      Version of Record online: 19 NOV 2007 | DOI: 10.1002/hep.21918

    9. You have free access to this content
    10. You have free access to this content
      Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice (pages 1769–1778)

      Jun Wu, Mengji Lu, Zhongji Meng, Martin Trippler, Ruth Broering, Agnes Szczeponek, Frank Krux, Ulf Dittmer, Michael Roggendorf, Guido Gerken and Joerg F. Schlaak

      Version of Record online: 10 OCT 2007 | DOI: 10.1002/hep.21897

  3. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Editorial
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Special Article
    11. Reviews
    12. Hepatology Elsewhere
    13. Correspondence
    14. Corrections
    1. You have free access to this content
      Fish oil prevents sucrose-induced fatty liver but exacerbates high-safflower oil-induced fatty liver in ddy mice (pages 1779–1790)

      Tomomi Yamazaki, Akiko Nakamori, Eriko Sasaki, Satoshi Wada and Osamu Ezaki

      Version of Record online: 12 OCT 2007 | DOI: 10.1002/hep.21934

    2. You have free access to this content
      Acute ethanol exposure inhibits insulin signaling in the liver (pages 1791–1800)

      Jiman He, Suzanne de la Monte and Jack R. Wands

      Version of Record online: 20 NOV 2007 | DOI: 10.1002/hep.21904

  4. Hepatobiliary Malignancies

    1. Top of page
    2. Editorial
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Special Article
    11. Reviews
    12. Hepatology Elsewhere
    13. Correspondence
    14. Corrections
    1. You have free access to this content
      Laminin-5 stimulates hepatocellular carcinoma growth through a different function of α6β4 and α3β1 integrins (pages 1801–1809)

      Carlo Bergamini, Concetta Sgarra, Paolo Trerotoli, Luigi Lupo, Amalia Azzariti, Salvatore Antonaci and Gianluigi Giannelli

      Version of Record online: 18 OCT 2007 | DOI: 10.1002/hep.21936

    2. You have free access to this content
  5. Autoimmune, Cholestatic and Biliary Disease

    1. Top of page
    2. Editorial
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Special Article
    11. Reviews
    12. Hepatology Elsewhere
    13. Correspondence
    14. Corrections
    1. You have free access to this content
      Randomized, double-blind, placebo-controlled trial of corticosteroids after Kasai portoenterostomy for biliary atresia (pages 1821–1827)

      Mark Davenport, Mark D. Stringer, Sarah A. Tizzard, Patricia McClean, Giorgina Mieli-Vergani and Nedim Hadzic

      Version of Record online: 12 OCT 2007 | DOI: 10.1002/hep.21873

    2. You have free access to this content
      The impact of ethnicity on the natural history of autoimmune hepatitis (pages 1828–1835)

      Sumita Verma, Michael Torbenson and Paul J. Thuluvath

      Version of Record online: 17 AUG 2007 | DOI: 10.1002/hep.21884

    3. You have free access to this content
      Quality of life and everyday activities in patients with primary biliary cirrhosis (pages 1836–1843)

      Carlo Selmi, M. Eric Gershwin, Keith D. Lindor, Howard J. Worman, Ellen B. Gold, Mitchell Watnik, Jessica Utts, Pietro Invernizzi, Marshall M. Kaplan, John M. Vierling, Christopher L. Bowlus, Marina G. Silveira and Ilaria Bossi

      Version of Record online: 20 NOV 2007 | DOI: 10.1002/hep.21953

  6. Liver Failure/Cirrhosis/Portal Hypertension

    1. Top of page
    2. Editorial
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Special Article
    11. Reviews
    12. Hepatology Elsewhere
    13. Correspondence
    14. Corrections
    1. You have free access to this content
      Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure (pages 1844–1852)

      William Bernal, Catherine Hall, Constantine J. Karvellas, Georg Auzinger, Elizabeth Sizer and Julia Wendon

      Version of Record online: 8 AUG 2007 | DOI: 10.1002/hep.21838

    2. You have free access to this content
      Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis (pages 1853–1862)

      Tarek I. Hassanein, Flemming Tofteng, Robert S. Brown Jr., Brendan McGuire, Patrick Lynch, Ravindra Mehta, Fin S. Larsen, Jeff Gornbein, Jan Stange and Andres T. Blei

      Version of Record online: 1 NOV 2007 | DOI: 10.1002/hep.21930

    3. You have free access to this content
      Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome (pages 1863–1871)

      Aleksander Krag, Søren Møller, Jens H. Henriksen, Niels-Henrik Holstein-Rathlou, Fin Stolze Larsen and Flemming Bendtsen

      Version of Record online: 20 NOV 2007 | DOI: 10.1002/hep.21901

    4. You have free access to this content
      Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure (pages 1872–1882)

      Dominique Thabut, Julien Massard, Alice Gangloff, Nicolas Carbonell, Claire Francoz, Eric Nguyen-Khac, Christian Duhamel, Didier Lebrec, Thierry Poynard and Richard Moreau

      Version of Record online: 30 OCT 2007 | DOI: 10.1002/hep.21920

    5. You have free access to this content
      Association of reduced extracellular brain ammonia, lactate, and intracranial pressure in pigs with acute liver failure (pages 1883–1892)

      Christopher Rose, Lars M. Ytrebø, Nathan A. Davies, Sambit Sen, Geir I. Nedredal, Mireille Belanger, Arthur Revhaug and Rajiv Jalan

      Version of Record online: 17 AUG 2007 | DOI: 10.1002/hep.21877

    6. You have free access to this content
      High-density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats (pages 1893–1906)

      Dominique Thabut, Khalid A. Tazi, Dominique Bonnefont-Rousselot, Maria Aller, Olivier Farges, Marie-Christine Guimont, Zera Tellier, Cecile Guichard, Eric Ogier-Denis, Thierry Poynard, Richard Moreau and Didier Lebrec

      Version of Record online: 4 OCT 2007 | DOI: 10.1002/hep.21875

    7. You have free access to this content
      Minimizing risk associated with elderly liver donors by matching to preferred recipients (pages 1907–1918)

      Dorry L. Segev, Warren R. Maley, Christopher E. Simpkins, Jayme E. Locke, Geoffrey C. Nguyen, Robert A. Montgomery and Paul J. Thuluvath

      Version of Record online: 4 OCT 2007 | DOI: 10.1002/hep.21888

  7. Liver Injury/Regeneration

    1. Top of page
    2. Editorial
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Special Article
    11. Reviews
    12. Hepatology Elsewhere
    13. Correspondence
    14. Corrections
    1. You have free access to this content
      Antiangiogenic treatment with Sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats (pages 1919–1926)

      Sònia Tugues, Guillermo Fernandez-Varo, Javier Muñoz-Luque, Josefa Ros, Vicente Arroyo, Juan Rodés, Scott L. Friedman, Peter Carmeliet, Wladimiro Jiménez and Manuel Morales-Ruiz

      Version of Record online: 12 OCT 2007 | DOI: 10.1002/hep.21921

    2. You have free access to this content
      Effect of an oral iron chelator or iron-deficient diets on uroporphyria in a murine model of porphyria cutanea tarda (pages 1927–1834)

      Nadia Gorman, Adrian Zaharia, Heidi S. Trask, Juliana G. Szakacs, Nicholas J. Jacobs, Judith M. Jacobs, Dominic Balestra, Jacqueline F. Sinclair and Peter R. Sinclair

      Version of Record online: 13 SEP 2007 | DOI: 10.1002/hep.21903

    3. You have free access to this content
      Efficient generation of human hepatocytes by the intrahepatic delivery of clonal human mesenchymal stem cells in fetal sheep (pages 1935–1945)

      Jason Chamberlain, Takashi Yamagami, Evan Colletti, Neil D. Theise, Jyoti Desai, Ana Frias, John Pixley, Esmail D. Zanjani, Christopher D. Porada and Graça Almeida-Porada

      Version of Record online: 17 AUG 2007 | DOI: 10.1002/hep.21899

  8. Liver Biology/Pathobiology

    1. Top of page
    2. Editorial
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Special Article
    11. Reviews
    12. Hepatology Elsewhere
    13. Correspondence
    14. Corrections
    1. You have free access to this content
    2. You have free access to this content
      Regulation of human liver δ-aminolevulinic acid synthase by bile acids (pages 1960–1970)

      Anne-Kathrin Peyer, Diana Jung, Markus Beer, Carmela Gnerre, Adrian Keogh, Deborah Stroka, Mihaela Zavolan and Urs-A. Meyer

      Version of Record online: 1 NOV 2007 | DOI: 10.1002/hep.21879

    3. You have free access to this content
      Clonal, cultured, murine fetal liver hepatoblasts maintain liver specification in chimeric mice (pages 1971–1978)

      Charles E. Rogler, Hong Chou Zhou, Lauretta LeVoci and Leslie E. Rogler

      Version of Record online: 12 OCT 2007 | DOI: 10.1002/hep.21894

    4. You have free access to this content
      Iron-mediated regulation of liver hepcidin expression in rats and mice is abolished by alcohol (pages 1979–1985)

      Duygu Dee Harrison-Findik, Elizabeth Klein, Callie Crist, John Evans, Nikolai Timchenko and John Gollan

      Version of Record online: 30 AUG 2007 | DOI: 10.1002/hep.21895

    5. You have free access to this content
      Glucocorticoid-induced leucine zipper: A key protein in the sensitization of monocytes to lipopolysaccharide in alcoholic hepatitis (pages 1986–1992)

      Haifa Hamdi, Amélie Bigorgne, Sylvie Naveau, Axel Balian, Laurence Bouchet-Delbos, Anne-Marie Cassard-Doulcier, Marie-Christine Maillot, Ingrid Durand-Gasselin, Sophie Prévot, Jocelyne Delaveaucoupet, Dominique Emilie and Gabriel Perlemuter

      Version of Record online: 28 NOV 2007 | DOI: 10.1002/hep.21880

    6. You have free access to this content
    7. You have free access to this content
  9. Special Article

    1. Top of page
    2. Editorial
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Special Article
    11. Reviews
    12. Hepatology Elsewhere
    13. Correspondence
    14. Corrections
    1. You have free access to this content
      Development of novel agents for the treatment of chronic hepatitis C infection: Summary of the FDA Antiviral Products Advisory Committee recommendations (pages 2014–2020)

      Kenneth E. Sherman, Russell Fleischer, Katherine Laessig, Jeffrey Murray, William Tauber and Debra Birnkrant

      Version of Record online: 20 NOV 2007 | DOI: 10.1002/hep.21985

  10. Reviews

    1. Top of page
    2. Editorial
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Special Article
    11. Reviews
    12. Hepatology Elsewhere
    13. Correspondence
    14. Corrections
    1. You have free access to this content
      Dendritic cells, the liver, and transplantation (pages 2021–2031)

      Tina L. Sumpter, Masanori Abe, Daisuke Tokita and Angus W. Thomson

      Version of Record online: 20 NOV 2007 | DOI: 10.1002/hep.21974

    2. You have free access to this content
  11. Hepatology Elsewhere

    1. Top of page
    2. Editorial
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Special Article
    11. Reviews
    12. Hepatology Elsewhere
    13. Correspondence
    14. Corrections
    1. You have free access to this content
      Hepatic Niemann-Pick C1–like 1: The canalicular side of the coin (pages 2040–2042)

      Michele Petruzzelli and Antonio Moschetta

      Version of Record online: 28 NOV 2007 | DOI: 10.1002/hep.22086

    2. You have free access to this content
      Identification of resident hepatic stem cell populations (pages 2042–2044)

      Nicholas A Shackel and Fiona J Warner

      Version of Record online: 28 NOV 2007 | DOI: 10.1002/hep.22091

  12. Correspondence

    1. Top of page
    2. Editorial
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Special Article
    11. Reviews
    12. Hepatology Elsewhere
    13. Correspondence
    14. Corrections
    1. You have free access to this content
      Effects of rosiglitazone on methionine-choline deficient diet-induced nonalcoholic steatohepatitis (page 2045)

      Veysel Tahan, Nese Imeryuz, Erol Avsar, Cigdem Celikel and Nurdan Tozun

      Version of Record online: 28 NOV 2007 | DOI: 10.1002/hep.21981

    2. You have free access to this content
      Reply: (pages 2045–2046)

      José A. Solís-Herruzo and Inmaculada García-Ruiz

      Version of Record online: 28 NOV 2007 | DOI: 10.1002/hep.22045

    3. You have free access to this content
      Coffee and hepatocellular carcinoma: Cause or confounding? (pages 2046–2047)

      Prachi S. Patil and Mohandas K. Mallath

      Version of Record online: 28 NOV 2007 | DOI: 10.1002/hep.22004

    4. You have free access to this content
      Reply: (page 2047)

      Francesca Bravi, Cristina Bosetti and Carlo La Vecchia

      Version of Record online: 28 NOV 2007 | DOI: 10.1002/hep.22041

    5. You have free access to this content
      Noninvasive diagnosis of nonalcoholic fatty liver disease using serum biomarkers (pages 2047–2048)

      Ragai R. Mitry, Ruth De Bruyne, Alberto Quaglia, Robin D. Hughes and Anil Dhawan

      Version of Record online: 28 NOV 2007 | DOI: 10.1002/hep.21998

    6. You have free access to this content
      Reply: (page 2048)

      Anna Wieckowska, Arthur J. McCullough and Ariel E. Feldstein

      Version of Record online: 28 NOV 2007 | DOI: 10.1002/hep.22055

    7. You have free access to this content
      Hepatitis C virus kinetics in chimeric mice during antiviral therapy (pages 2048–2049)

      Harel Dahari and Alan S. Perelson

      Version of Record online: 12 OCT 2007 | DOI: 10.1002/hep.21798

    8. You have free access to this content
      Hepatitis C virus RNA kinetics in chimeric mice with human hepatocytes during antiviral therapy (pages 2049–2050)

      Kazuaki Inoue, Tsunamasa Watanabe, Makoto Yoshiba and Michinori Kohara

      Version of Record online: 15 OCT 2007 | DOI: 10.1002/hep.22000

    9. You have free access to this content
      Adipokines and insulin resistance in chronic hepatitis C (pages 2050–2051)

      Emmanuel Tsochatzis, George V. Papatheodoridis and Athanasios J. Archimandritis

      Version of Record online: 28 NOV 2007 | DOI: 10.1002/hep.22005

    10. You have free access to this content
      Reply: (page 2051)

      Ian Homer Y. Cua and Jacob George

      Version of Record online: 28 NOV 2007 | DOI: 10.1002/hep.22058

  13. Corrections

    1. Top of page
    2. Editorial
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Special Article
    11. Reviews
    12. Hepatology Elsewhere
    13. Correspondence
    14. Corrections
    1. You have free access to this content
      Correction (page 2052)

      Version of Record online: 28 NOV 2007 | DOI: 10.1002/hep.22078

    2. You have free access to this content
      Correction (page 2052)

      Version of Record online: 16 OCT 2007 | DOI: 10.1002/hep.22077

    3. You have free access to this content
      Correction (page 2052)

      Version of Record online: 28 NOV 2007 | DOI: 10.1002/hep.22114

SEARCH

SEARCH BY CITATION